Loading news...
Ambac Financial Group, Inc. (NYSE: AMBC - Get Free Report)'s share price fell 0.4% during trading on Monday. The company traded as low as $8.86 and last traded at $9.04. 838,741 shares changed hands during mid-day trading, a decline of 12% from the average session volume of 954,617 shares. The stock had previously closed at
Aurelius Capital Management LP bought a new stake in shares of Ambac Financial Group, Inc. (NYSE: AMBC) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 60,546 shares of the company's stock, valued at approximately $430,000. Ambac Financial Group makes up
AXQ Capital LP increased its holdings in shares of Ambac Financial Group, Inc. (NYSE: AMBC) by 27.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 35,439 shares of the company's stock after acquiring an additional 7,694 shares during the quarter. AXQ
Ambac (AMBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The mean of analysts' price targets for Ambac (AMBC) points to a 48% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ambac Financial Group, Inc. ( AMBC ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Karen Beyer - MD & Head of Investor Relations Claude LeBlanc - President, CEO & Director David Trick - Executive VP, CFO & Treasurer Conference Call Participants Mark Hughes - Truist Securities, Inc., Research Division Presentation Operator Ladies and gentlemen, good morning, and welcome to the Octave Specialty Group's Third Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Ambac Financial Group (AMBC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.46 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Ambac Financial Group Rebrands as Octave Specialty Group, Inc.
NEW YORK--(BUSINESS WIRE)--Ambac Reports Third Quarter 2025 Results.
NEW YORK--(BUSINESS WIRE)--Ambac Financial Group Appoints Karen Beyer Head of Investor Relations.
NEW YORK--(BUSINESS WIRE)--Ambac Financial Group Completes Acquisition of ArmadaCare.
NEW YORK--(BUSINESS WIRE)--Ambac to Release Third Quarter Earnings on November 10, 2025.
CHARLOTTE, N.C.--(BUSINESS WIRE)--Ambac Subsidiary Beat Capital Partners Launches 1889 Specialty Insurance Services.
Brisbane, Queensland, Australia--(Newsfile Corp. - October 13, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") announces new leadership at Australia's Peak Battery industry association of the Advanced Materials and Battery Council (AMBC).
Ambac Financial Group, Inc. (NYSE:AMBC ) M&A Call September 30, 2025 8:30 AM EDT Company Participants Kate Smith - Director of Corporate Communications Claude LeBlanc - President, CEO & Director David Trick - Executive VP, CFO & Treasurer Naveen Anand - President of Cirrata Group Conference Call Participants Maxwell Fritscher - Truist Securities, Inc., Research Division Presentation Operator Ladies and gentlemen, good morning, and welcome to the Ambac Financial Group Investor Meeting. [Operator Instructions] As a reminder, this conference is being recorded.
NEW YORK--(BUSINESS WIRE)--Ambac Financial Group to Acquire Leading Supplemental Health Program Manager ArmadaCare.
NEW YORK--(BUSINESS WIRE)--Ambac Financial Group Completes Sale of Its Legacy Financial Guarantee Businesses to Oaktree.
Ambac's turnaround story hinges on the imminent sale of its legacy business to Oaktree, with a key regulatory hearing set for September 3. Despite a 24% stock decline, AMBC has executed on its transition to specialty P&C insurance, growing its distribution segment nearly 5x year-over-year. The legacy sale would radically improve the company's balance sheet, eliminate debt, and boost book value to $15.35 per share—well above the current price.